Brief: Merck KGaA Completes Acquisition Of Springworks Therapeutics
01/07/2025 13:37
July 1 (Reuters) - MERCK KGAA MRCG.DE: COMPLETES ACQUISITION OF SPRINGWORKS THERAPEUTICS TO ACCELERATE SUSTAINABLE GROWTH OF ITS HEALTHCARE BUSINESS Further company coverage: MRCG.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SpringWorks Therapeutics
See all newsBrief: Merck KGaA Completes Acquisition Of Springworks Therapeutics
Brief: Springworks Therapeutics Expects Nirogacestat Decision From European Commission In Q3
Brief: EMA's CHMP Re-Examines Rejection Of Kisunla For Early Alzheimer’S Treatment
Brief: SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN
Brief: SpringWorks Therapeutics Receives Positive CHMP Opinion For Mirdametinib For The Treatment Of Adult And Pediatric Patients With NF1-PN